A new in situ, personalized cancer vaccine captures molecules from growing tumors to activate the body’s immune cells against them.
Module labs are a polarizing plan for COVID-19 vaccine manufacturing in Africa
Without independent vaccine manufacturing in Africa, the social and economic costs of the pandemic will only be prolonged.
Vaccine misinformation moderately curbed by new Facebook policy
New study provides evidence that social media companies have the tools to reduce the impact of vaccine misinformation on their platforms.
Corbevax vaccine offers solution to global vaccine inequity
The Corbevax COVID-19 vaccine was developed by researchers in Texas with no patent, and could be the end of global vaccine inequity.
Computer simulations pave the way for improved mRNA vaccines
Molecular dynamics offer ways to improve lipid-based therapeutic delivery systems.
Omicron reduces vaccine efficacy, but boosters improve protection
Preliminary data indicates that booster shots improve antibody levels 25-fold compared to just two doses.
An inhaled COVID-19 vaccine makes it to human trials
The aerosol platform promises broader protection against SARS-CoV-2, and is currently being trialed as a booster.
Shining a light on more efficient nasal vaccines
Nanoparticulate formula together with light augmentation could realize the potential for intranasal vaccines to protect against respiratory viruses.
New breast cancer vaccine enters phase I clinical trial
A new vaccine aims to prevent one of the most aggressive forms of breast cancer.
Biomaterial-based COVID-19 vaccine shows adaptive immunity in mice
A biomaterials platform offers a stable center within the body for antibody development against SARS-CoV-2.